HEPATITIS B E ANTIGEN [imft]    
liver resection [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Hepatitis B, Chronic [dsyn]    
Effects [qlco]    
serum Hepatitis B e antigen [lbpr]    
findings [ftcn]    
liver resection [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Hepatitis B, Chronic [dsyn]    
Series [qnco]    
Patients [podg]    
Curative [cnce]    
resection [topp]    
Divided [ftcn]    
Groups [idcn]    
HEPATITIS B E ANTIGEN [imft]    
Patients [podg]    
Group 1 [inpr]    
hepatitis b e antigen negative [lbtr]    
Patients [podg]    
Group 2 [inpr]    
LOWER [spco]    
Group I [inpr]    
Group 2 [inpr]    
Proportion [qnco]    
Patients [podg]    
symptoms [ftcn]    
Significantly high [qnco]    
Group I [inpr]    
Group 2 [inpr]    
Clinical findings [sosy]    
Groups [idcn]    
Including [ftcn]    
Laboratory Test Result [fndg]    
Medical [hlca]    
condition [dsyn]    
operative methods [ftcn]    
Tumour size [spco]    
Degree [qlco]    
Differentiation [celf]    
Main [qlco]    
Tumour NOS [neop]    
Vascular [bpoc]    
Invasion [fndg]    
Groups [idcn]    
Intrahepatic [spco]    
Metastasis [neop]    
Proportion [qnco]    
Patients [podg]    
active hepatitis [fndg]    
Significantly high [qnco]    
Group I [inpr]    
Group 2 [inpr]    
Tumour NOS [neop]    
free [ftcn]    
Survival Rates, Cumulative [qnco]    
LOWER [spco]    
Group I [inpr]    
Group 2 [inpr]    
0.022" [qnco]    
Various [irda]    
Risk Factors [qnco]    
serum Hepatitis B e antigen [lbpr]    
Independent [idcn]    
Risk Factor [qnco]    
Recurrence Risk [qnco]    
RATIO [qnco]    
Independent [idcn]    
Unfavorable [qlco]    
Survival time [clna]    
Risk Ratio [qnco]    
cl-2 [gngm]    
liver resection [topp]    
HCC [neop]    
worse [qlco]    
HEPATITIS B E ANTIGEN [imft]    
Patients [podg]    
hepatitis b e antigen negative [lbtr]    
Patients [podg]    
